N/A N=16 Treatment

Increasing Physical Activity Among Breast Cancer Survivors With Depression

Depression · Physical Activity · Breast Cancer

Bottom Line

View on ClinicalTrials.gov: NCT02781051 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2019

Primary outcome: Primary: Moderate-to-vigorous Physical Activity Measured by Actigraph Accelerometer — 56.2 minutes per week

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Print-based education (Behavioral); Fitbit (Device); Active Living counseling (Behavioral); Facility Access (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: University of Texas Southwestern Medical Center
Primary completion: Sep 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Moderate-to-vigorous Physical Activity Measured by Actigraph Accelerometer	56.2	—
SECONDARY Depressive Symptoms Measured by the Quick Inventory of Depressive Symptomatology - Self Report(QIDS-SR)	9.7	—

Summary

Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

Eligibility Criteria

Inclusion Criteria

Positive depression screen (PHQ-9) or current antidepressant treatment
Report <150 minutes of weekly moderate-to-vigorous physical activity (MVPA) on the GPAQ
Physically able to engage in physical activity
Written and verbal fluency in English

Exclusion Criteria

Medical condition contraindicating physical activity participation
Recurrence of breast cancer
Ductal carcinoma in situ (DCIS) diagnosis
Cognitively unable to give informed consent
Non-English speaking

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02781051). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.